Pharmacy Practice
Affordable Medicines
Biosimilars
Compliance
Compounding
Drug Approvals
Geriatrics
Hospital/Health System
In-Pharmacy Vaccines
Law
Medication Management
News & Trends
OTC
Pharmacist Resources
Pharmacy Technician
Pharmacy Week
Specialty Pharmacy
Technology
Disease State
Allergy
Autoimmune
Breast Cancer
Cardiovascular
Cold & Flu
COPD
COVID-19
Dermatology
Diabetes
Epilepsy
Gastroenterology
Hematology
Hepatitis
HIV/AIDS
Huntington's Disease
Infectious Disease
Infusion
Lung Cancer
Mental Health
mRNA Technology
Neurology
Oncology
Ophthalmology
Orthopedics
Pain Management
Pediatrics
Respiratory
Rheumatoid Arthritis
RSV
Schizophrenia
Shingles
Transplant
Urology/Nephrology
Women’s Health
Health Awareness Month
Videos
Patient Teaching Aid
Publications
Featured Issue
Featured Supplements
Conference Coverage
Continuing Education
Subscribe
October 2024
Archives
Subscription
Features
Doxycycline Guidelines for STI Postexposure Prophylaxis
New Drug Review 2024
Novel Strategy for Preventing Cardiovascular Disease in Patients With HIV
Review of Selected NMEs 2024
The Pharmacist’s Role in Antimicrobial Stewardship
Departments
Contemporary Compounding
Chloroquine Phosphate 16.7 mg/mL Oral Suspension
Pharmacy and Technology
Industry News
Pharmacy Focus
The Xylazine Public Health Emergency
TrendWatch
The Rise of Cell and Gene Therapies
X
October 2024
In This Issue
Archives
Subscription
Continuing Education
$7.95 Per CE Exam or $69 for 12 Lessons
• January 2025
• 2.00 Credits
Neuropsychiatric Complications of Psoriasis and Its Treatment
×
Full Image